Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.

Registration

Registration

NCT07154238

Acronym

OUTSTEP-1

Study type

OBSERVATIONAL

Status

ENROLLING_BY_INVITATION

Enrollment

2546

Start

2025-09-26

Primary completion

2026-09-30

Lead sponsor

Novo Nordisk A/S

Conditions

Obesity

Interventions

OTHER:No treatment given

Results posted

FALSE

Individual participant data sharing

YES

Secondary identifiers

OTHER:U1111-1314-6149

Registered primary outcomes

• Description of characteristics, including clinical, demographic and physical characteristics, among individuals initiated on injectable semaglutide for weight management [At the time of survey response (Day 1)]
• Description of the experience of individuals initiated on injectable semaglutide for weight management through personal perception of physical and mental health and self-reported QoL [At the time of survey response (Day 1)]
• Individual-reported change in BMI since initiation [At the time of survey response (Day 1)]
• Individual-reported achievement of weight loss goal [At the time of survey response (Day 1)]
• Individual-reported change in weight since initiation [At the time of survey response (Day 1)]
• Individual-reported changes in daily life since initiation on injectable semaglutide [At the time of survey response (Day 1)]